Back to top

View the PFP Archive

Stocks Closed Lower On Friday And The Week, More Earnings And The Fed On Tap For This Week
Kevin Matras   
Profit from the Pros
By Kevin Matras
Executive Vice President
Zacks Investment Research
  

Stocks Closed Lower On Friday And The Week, More Earnings And The Fed On Tap For This Week

Stocks closed mostly lower on Friday in uneven trade. The S&P eked out a 0.03% gain, while the Nasdaq was up 0.28%. On the downside was the Dow, which gave up -0.58%, with the small-cap Russell 2000 and mid-cap S&P 400 falling by -1.82% and -1.00% respectively.

But all of the major indexes closed lower for the week, albeit not by much.

At the start of last week, tensions over U.S. interest in Greenland, and the threat of a 10% tariff on NATO countries who opposed it, weighed on stocks at the beginning of the week. But by mid-week, stocks bounced back after President Trump said he "won't use force" on Greenland. And following an announcement that a "framework of a future deal" over Greenland was reached, he said he would "not be imposing the tariffs that were scheduled to go into effect on February 1st."

Supporting the rebound was a better-than-expected third and final estimate for Q3'25 GDP, which came in at 4.4%, up from last month's 4.3%, and the original estimate of 3.2%. (Not to mention Q4'25 is forecast at an even stronger 5.4%.)

And the latest Personal Consumption Expenditures (PCE) index (for November) showed core inflation (ex-food & energy) easing to 2.8% y/y vs. October's 2.9% and September's 3.0%.

Earnings season is also off to a strong start. And it picks up steam this week with more than 480 companies on deck to report, including 4 of the Magnificent 7 stocks (Microsoft, Meta and Tesla on Wednesday 1/28, and Apple on Thursday 1/29), along with other widely held names like Texas Instruments, Starbucks, Visa, Exxon Mobile and IBM throughout the week.

Earnings season is always an exciting time since stocks typically go up during earnings season.

But we could see more volatility after President Trump said he would impose a 100% tariff on Canadian goods if Canada signs a deal with China that the U.S. believes could result in a "drop-off port" for Chinese goods to make their way to the U.S. and bypass their tariffs.

In other news, on Wednesday, 1/28, we'll hear from the Fed on interest rates. Nobody is expecting a cut this month (only 4.4% odds). But the likelihood increases to 15.4% in March, 29.4% in April, and 60.6% in June (when the new Fed Chair is expected to replace current Chair Jerome Powell after his term expires in May). But you can be sure everybody will be listening to Mr. Powell's Press Conference afterwards for insight on the Fed's outlook on inflation, economic growth and future rate cuts.

Three weeks into the new year and the markets are off to a good start. YTD, the Dow is up 2.15%; the S&P is up 1.02%; the Nasdaq is up 1.12%; the Russell 2000 is up 7.54%; and the S&P 400 is up 5.49%. It's also interesting to note that the equal-weighted S&P 500 index is up 3.71% vs. the market-weighted 1.02%, showing the strength of smaller-cap names (in this case upper mid-cap names), vs. the larger- and mega-caps. A couple percent isn't huge. But combined with the outsized performance of the small and mid-cap indexes, it shows the broadening of the rally, which is a bullish sign.

See you tomorrow,

Kevin Matras

Executive Vice President, Zacks Investment Research

Sponsor

Beat Wall Street to the Trade

Med-X is preparing for a Nasdaq listing (MXRX)?but by the time the bell rings, it may be too late. Already generating $6.4M in revenue, its Nature-Cide line is sold e-commerce giants like Amazon, Walmart, and Kroger and is expanding into 41+ markets.

As regulators, consumers, and climate pressure push the $17B pest control industry natural, Med-X is positioned to lead. Right now, shares are just $4.00 through a limited Reg A+ offering.

Become a Med-X Shareholder Before Their Nasdaq Plans Unfold


Disclosures: This is a paid advertisement for Med-X's Regulation A+ Offering. Please read the offering circular at invest.medx-rx.com

Most Popular Articles from Zacks.com

Image: Bigstock

Magnificent 7 Earnings Loom: What to Expect?

Q4 earnings reporting cycle ramps up this week, with more than 300 companies on deck to report results, including four of the 'Magnificent 7' members. Read More »

Image: Bigstock

Up 40%+ in 2025: 3 Stocks on the Verge of a Massive 2026 Breakout

BKD, ITUB and VALE stand out as potential breakout stocks for 2026. Read More »

Image: Bigstock

Intel vs. TSMC: Can Intel Close the Gap?

The investment case for Intel (INTC) now hinges almost entirely on its ability to reinvent itself as a competitive, high-end foundry operator, that can compete with the likes of Taiwan Semiconductor (TSM). Read More »

Image: Bigstock

Software Stocks Have Plunged: Steals or Traps?

Having plunged to start the new year, software companies like Twilio (TWLO), Salesforce (CRM) and Adobe(ADBE) are expected to grow their earnings in 2026. Read More »

Image: Bigstock

4 Stocks Trading Near 52-Week High With More Upside Potential

Near their 52-week highs, IPGP, DG, IRWD and SAIC show potential for continued upside with strong earnings growth and positive price momentum. Read More »

Sponsor

Why Haven't You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +7.7 average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.

Today you can access their live picks without cost or obligation.

See Stocks Free »

Image: Bigstock

Bull of the Day: Nvidia (NVDA)

Nvidia's transformation from a gaming pioneer to the bedrock of the global AI revolution has solidified its future growth. Read More »

New Zacks Strong Buys for January 26th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today. Read More »

 

Download our app for convenient on-the-go access to even more—daily and weekly newsletters published by Zacks experts, proprietary research and tools, and Portfolio Tracker on Zacks.com.

Download our Zacks App for Apple iOS
Download our Zacks App for Android

Visit Success Stories to hear how Zacks research, tools and portfolios help our members outperform the market.